# OnCo record vulvar (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/vulvar/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "vulvar" ;
  schema:name "Vulvar cancer"@en ;
  schema:description "An uncommon cancer of the external genitalia with two distinct causes: HPV infection in younger women and chronic skin inflammation in older women. Surgery is the mainstay, and sentinel-node biopsy has made it far less mutilating."@en ;
  schema:url <https://onco.cc/cancers/vulvar/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Vulvar_cancer> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1908194> ;
  schema:citation <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1476>, <https://doi.org/10.1200/JCO.21.00006>, <https://www.cancer.gov/types/vulvar/patient/vulvar-treatment-pdq> ;
  onco:tag "gap-fill", "gynaecologic", "hpv" ;
  onco:related <https://onco.cc/cancers/vaginal/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/tp53/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/gardasil-9/> ;
  onco:companies <https://onco.cc/companies/merck/>, <https://onco.cc/companies/regeneron/> ;
  onco:terms <https://onco.cc/terms/hpv-p16/>, <https://onco.cc/terms/cps/> ;
  onco:trials <https://onco.cc/trials/nct04422366/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/lorigerlimab/> ;
  onco:standardOfCare <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/pembrolizumab/> .